GSK Plc (GSK)

59.09 -0.43 (-0.72%) USD  |  NYSE  |  Feb 23, 15:11
More

GSK Ending Cash (Quarterly)

Ending Cash (Quarterly) Chart

View Ending Cash (Quarterly) for GSK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Ending Cash (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Ending Cash (Quarterly) Range, Past 5 Years

View Ending Cash (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Ending Cash (Quarterly) Benchmarks

View Ending Cash (Quarterly) Benchmarks
Start Trial
AstraZeneca PLC Upgrade
Mereo BioPharma Group Plc Upgrade
Novavax, Inc. Upgrade
Biodexa Pharmaceuticals Plc --
AnaptysBio, Inc. Upgrade